HSDT (Helius Medical) Price Chart

Corporate emblem and logo of heliusmedical.com (HSDT)

The financial price chart for Helius Medical (HSDT) demonstrates the dynamics of an asset whose operating cycle relies on partnerships with external component manufacturing plants under strict quality control. The current metric stands at 1.84. System reliability is guaranteed by the implementation of automated assembly lines instead of manual labor. Consequently, Helius Medical (HSDT) maintains niche superiority by investing in the development of an intellectual platform for the therapy of motor disorders.

HSDT - Helius Medical Technologies Share Price over the range 07/04/2022 - 11/11/2026

Helius Medical Technologies Inc. (HSDT) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
- business market valuation indicators:
Analysis of all company metrics:Helius Medical Technologies HSDT
Signature product of Helius Medical Technologies Inc.

Investors view the market value of Helius Medical (HSDT) as an indicator of confidence in the potential of neurostimulation for post-stroke rehabilitation. This metric reflects the current equilibrium of supply and demand, capturing the market's readiness to capitalize on the company's success in overcoming physician conservatism and expanding insurance coverage, which clearly demonstrates the shift in market value upon reaching critical price levels.

Analysis of competing companies

Stock Price BIIB|NBIX (neurocrine.com) - Price Performance Chart|Price Chart Regencell Bioscience Holdings Limited RGC|Market Chart Axsome (AXSM)|ACADIA Pharmaceuticals Inc - Stock Price|XENE (Xenon Corp) - Share Price|VKTX (Viking Therapeutics) - Stock Quotes|SUPN: Price|Price Chart Catalyst Pharmaceuticals, Inc.|Share Price DNLI (Denali)|Stock Price HRMY|BHVN - Market Price|Amylyx Pharmaceuticals - Stock Quotes|Stock Price trevitherapeutics.com TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex)|CeriBell Corp (CBLL) - Price Chart|Market Price Prothena Corporation plc (PRTA)|ALEC (Alector Inc.) - Stock Price|ANNX: Price Performance Chart|Stock Price OMER|NGNE - Market Price|Price Chart AC Immune Corp ACIU|Voyager Corp - Price Chart|Neumora Therapeutics - Stock Price|Market Chart scilexholding.com SCLX|TVGN (Tevogen Bio) - Stock Quotes|Alpha Cognition Inc. (ACOG) - Stock Price|Price Chart Cognition Therapeutics|Inhibikase Pharma (IKT) - Market Chart|Stock Quotes SAVA (Cassava Sciences, Inc.)|ASRT (assertiotx.com) - Price Performance Chart|Price Chart Coya Therapeutics COYA|VTGN - Stock Quotes|Ovid Rx - Stock Price|Market Price Acumen Pharmaceuticals, Inc|CRVO: Stock Price|Share Price ATHE|CLNN (Clene Inc) - Stock Price|PepGen Corp (PEPG) - Market Chart|Stock Price JUNS|Stock Quotes Relmada Corp RLMD|Stock Price ANVS (Annovis Bio, Inc.)|Stock Price Grace Therapeutics Inc GRCE|AIFF - Price Chart|KLTO: Price Chart|NRSN: Stock Price|Reviva Pharmaceuticals, Inc. - Price Performance Chart|Price Chart MetaVia Inc.|neuraxis.com (NRXS) - Market Chart|Stock Price PASG|bionomics.com.au - Share Price|Minerva Neurosciences Corp - Stock Quotes|Price ATHA (Athira Pharma Corp)|ADXN - Price Chart|ALZN (Alzamend Neuro, Inc.) - Share Price|CYCN: Stock Price|Market Price Protagenic Therapeutics, Inc. (PTIX)|Stock Quotes KTTA|Stock Price Cortigent Medical|Price Chart Avenue Therapeutics (ATXI)|BCLI (brainstorm-cell.com) - Price Performance Chart|Price Chart Cara Therapeutics CARA|Chromocell Therapeutics Corp (CHRO) - Market Price|Eliem - Stock Price|Price Performance Chart ITCI (Intra-Cellular Therapies)|LBPH: Stock Price|Market Price marinuspharma.com (MRNS)|Price Chart NKGen Biotech|Price Chart NRBO|Stock Price SAGE|Market Chart Synaptogenix, Inc|Trevena, Inc. - Stock Quotes|Stock Price Vigil Neuroscience Inc. VIGL|WENA - Price Chart|Market Chart Cerevel Therapeutics Inc CERE